Lipidem

Soybean oil refined, medium-chain triglycerides, the active ingredient in Lipidem, is an excipient (intravenous lipid solvent) presented as a sterile intravenous solution for intravenous use. It provides a lipid source and solvent for the intravenous administration of drugs and nutrients.

GNH USA supplies Lipidem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide.

Lipidem is used as a lipid component in parenteral nutrition and as a vehicle for intravenous drug formulations. - Parenteral nutrition: supplies essential calories and essential fatty acids for patients receiving total parenteral nutrition. - Intravenous drug vehicle: acts as a solvent for lipid‑soluble medications administered by infusion. - Lipid emulsion adjunct: supports the stability and compatibility of mixed intravenous nutrient solutions.

Lipidem may be associated with several adverse reactions following intravenous administration.

Common Side Effects: - Hypertriglyceridemia: elevated blood triglyceride levels. - Fever: transient rise in body temperature. - Infusion site reactions: erythema, pain, or swelling at the catheter site. - Nausea: mild gastrointestinal discomfort. - Hypotension: transient drop in blood pressure during infusion.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical intervention. - Fat overload syndrome: accumulation of excess lipid leading to organ dysfunction. - Pulmonary embolism: lipid emboli causing respiratory compromise. - Hepatic dysfunction: abnormal liver enzyme elevations. - Coagulopathy: impaired blood clotting due to lipid interaction.

When using Lipidem, consider the following safety measures. - Patient assessment: evaluate baseline triglyceride levels and lipid metabolism disorders. - Monitoring: regularly check serum lipids, liver function, and respiratory status during therapy. - Compatibility: verify compatibility with co‑administered drugs to avoid precipitation. - Infusion rate: adhere to recommended infusion rates to minimize infusion‑related reactions. - Storage: Store at ambient temperature: keep in original container, protect from light and moisture.

Lipidem can interact with other therapies that affect lipid metabolism or fluid balance.

Major Interactions (Avoid): - Concurrent lipid emulsions: may cause severe hypertriglyceridemia. - Propofol infusion: additive lipid load can precipitate fat overload syndrome. - High‑dose corticosteroids: increase risk of elevated triglycerides.

Moderate Interactions (Monitor Closely): - Heparin therapy: may alter triglyceride clearance. - Diuretic use: monitor fluid and electrolyte status. - Insulin therapy: may require adjustment of glucose control due to altered lipid metabolism.